|
ATE427948T1
(de)
|
2001-04-24 |
2009-04-15 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
|
CA2484640C
(en)
*
|
2002-05-15 |
2012-01-17 |
Endocyte, Inc. |
Vitamin-mitomycin conjugates
|
|
DK1523493T3
(da)
*
|
2002-07-09 |
2013-12-02 |
Alexander Doemling |
Nye tubulysinanaloge
|
|
WO2004069159A2
(en)
|
2003-01-27 |
2004-08-19 |
Endocyte, Inc. |
Vitamin receptor binding drug delivery conjugates
|
|
CN101098854B
(zh)
*
|
2004-07-23 |
2012-12-05 |
恩多塞特公司 |
二价连接体及其轭合物
|
|
CN101175757B
(zh)
*
|
2005-03-16 |
2012-11-14 |
恩多塞特公司 |
蝶酸及其缀合物的合成和纯化
|
|
EP2382995A3
(en)
*
|
2005-08-19 |
2013-09-25 |
Endocyte, Inc. |
Ligand conjugates of Vinca alkaloids, analogs and derivatives
|
|
BRPI0615354A2
(pt)
*
|
2005-08-19 |
2011-05-17 |
Endocyte, Inc. |
conjugado de liberação de fármaco de ligação de receptor, composição farmacêutica que o compreende, bem como seu uso
|
|
US20100104626A1
(en)
*
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
AU2008224988A1
(en)
*
|
2007-03-14 |
2008-09-18 |
Endocyte, Inc. |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
WO2008138561A1
(en)
*
|
2007-05-10 |
2008-11-20 |
R & D Biopharmaceuticals Gmbh |
Tubulysine derivatives
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
EP2181101A2
(en)
*
|
2007-07-20 |
2010-05-05 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Tubulysin d analogues
|
|
US8476451B2
(en)
*
|
2007-07-20 |
2013-07-02 |
The Regents Of The University Of California |
Tubulysin D analogues
|
|
CN101909441B
(zh)
*
|
2007-10-25 |
2015-05-13 |
恩多塞特公司 |
微管蛋白抑制剂及其制备方法
|
|
EP2174947A1
(en)
*
|
2008-09-25 |
2010-04-14 |
Universität des Saarlandes |
Bioactive pre-tubulysins and use thereof
|
|
IT1394860B1
(it)
*
|
2009-07-22 |
2012-07-20 |
Kemotech S R L |
Composti farmaceutici
|
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
|
EP2409983A1
(en)
|
2010-07-19 |
2012-01-25 |
Leibniz-Institut für Pflanzenbiochemie (IPB) |
Tubulysin analogues
|
|
JP2013535220A
(ja)
|
2010-08-06 |
2013-09-12 |
エンドサイト，インコーポレイテッド |
ツブリシンを調製するためのプロセス
|
|
WO2012171020A1
(en)
|
2011-06-10 |
2012-12-13 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
RU2014124984A
(ru)
*
|
2011-12-05 |
2016-01-27 |
Идженика Биотерапьютикс, Инк. |
Конъюгаты антитело-лекарственное средство и родственные соединения, композиции и способы
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
CN104640572B
(zh)
|
2012-05-15 |
2018-04-27 |
索伦托医疗有限公司 |
药物偶联物，偶联方法，及其用途
|
|
ES2781523T3
(es)
|
2012-07-12 |
2020-09-02 |
Hangzhou Dac Biotech Co Ltd |
Conjugados de moléculas de unión celular con agentes citotóxicos
|
|
US11873281B2
(en)
|
2012-07-12 |
2024-01-16 |
Hangzhou Dac Biotech Co., Ltd. |
Conjugates of cell binding molecules with cytotoxic agents
|
|
EP2708243A1
(en)
|
2012-09-17 |
2014-03-19 |
OntoChem GmbH |
Receptor ligand linked cytotoxic molecules
|
|
BR112015008365A2
(pt)
|
2012-10-16 |
2017-07-04 |
Endocyte Inc |
composto da fórmula b-l(d)x, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composição de forma de dosagem unitária ou dose unitária, composição para tratar um câncer em um paciente, e método para tratar um câncer em um paciente
|
|
EA201590783A1
(ru)
|
2012-11-15 |
2015-11-30 |
Эндосайт, Инк. |
Конъюгаты для доставки лекарственных средств и способы лечения заболеваний, вызванных клетками, экспрессирующими psma
|
|
CA2891280C
(en)
|
2012-11-24 |
2018-03-20 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
CA2892863C
(en)
|
2012-12-10 |
2022-03-15 |
Mersana Therapeutics, Inc. |
Polymeric scaffold based on phf for targeted drug delivery
|
|
WO2014093640A1
(en)
|
2012-12-12 |
2014-06-19 |
Mersana Therapeutics,Inc. |
Hydroxy-polmer-drug-protein conjugates
|
|
LT2956173T
(lt)
|
2013-02-14 |
2017-06-26 |
Bristol-Myers Squibb Company |
Tubulizino junginiai, gavimo ir panaudojimo būdai
|
|
US20140249315A1
(en)
|
2013-03-01 |
2014-09-04 |
Endocyte, Inc. |
Processes for preparing tubulysins
|
|
US10781259B2
(en)
|
2013-06-06 |
2020-09-22 |
Magenta Therapeutics, Inc. |
Modified antibodies and related compounds, compositions, and methods of use
|
|
NZ758049A
(en)
|
2013-10-15 |
2024-03-22 |
Seagen Inc |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
AU2014337317A1
(en)
|
2013-10-15 |
2016-09-15 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
WO2015113760A1
(en)
*
|
2014-01-28 |
2015-08-06 |
Tube Pharmaceuticals Gmbh |
Cytotoxic tubulysin compounds for conjugation
|
|
US10464955B2
(en)
|
2014-02-28 |
2019-11-05 |
Hangzhou Dac Biotech Co., Ltd. |
Charged linkers and their uses for conjugation
|
|
SG11201608192SA
(en)
|
2014-04-11 |
2016-10-28 |
Medimmune Llc |
Bispecific her2 antibodies
|
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
|
CN112826940A
(zh)
*
|
2014-11-11 |
2021-05-25 |
杭州多禧生物科技有限公司 |
细胞毒素分子同细胞结合受体分子的共轭体
|
|
EP3250238B1
(en)
|
2015-01-28 |
2022-06-01 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
NZ739830A
(en)
|
2015-07-12 |
2021-12-24 |
Hangzhou Dac Biotech Co Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
MY192146A
(en)
|
2015-11-10 |
2022-08-01 |
Medimmune Llc |
Binding molecules specific for asct2 and uses thereof
|
|
KR20180090290A
(ko)
|
2015-12-04 |
2018-08-10 |
시애틀 지네틱스, 인크. |
사차화 튜불리신 화합물들의 컨쥬게이트들
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
CN109843919A
(zh)
|
2016-03-25 |
2019-06-04 |
西雅图基因公司 |
用于制备聚乙二醇化的药物-接头及其中间体的方法
|
|
KR20220150408A
(ko)
|
2016-11-14 |
2022-11-10 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
|
KR102648564B1
(ko)
|
2017-03-24 |
2024-03-19 |
씨젠 인크. |
글루쿠로니드 약물-링커의 제조 공정 및 그 중간물
|
|
MA51447A
(fr)
|
2017-08-01 |
2020-06-10 |
Medimmune Llc |
Conjugué anticorps monoclonal-médicament dirigé contre bcma
|
|
CN114040778A
(zh)
|
2019-06-29 |
2022-02-11 |
杭州多禧生物科技有限公司 |
一种细胞结合分子-Tubulysin衍生物偶联物及其制备方法
|
|
US20220241377A1
(en)
|
2019-07-24 |
2022-08-04 |
Molgenie GmbH |
Receptor-targeting peptide-drug conjugates
|
|
BR112023004415A2
(pt)
|
2020-09-11 |
2023-05-09 |
Medimmune Ltd |
Moléculas terapêuticas de ligação a b7-h4
|
|
EP4426727A2
(en)
|
2021-11-03 |
2024-09-11 |
Hangzhou Dac Biotech Co., Ltd. |
Specific conjugation of an antibody
|
|
GB202117928D0
(en)
|
2021-12-11 |
2022-01-26 |
Cancer Research Tech Ltd |
Immunotherapy for cancer
|
|
EP4489859A1
(en)
|
2022-03-09 |
2025-01-15 |
Astrazeneca AB |
Binding molecules against fr alpha
|
|
CN120936382A
(zh)
|
2023-02-16 |
2025-11-11 |
阿斯利康(瑞典)有限公司 |
采用治疗性结合分子治疗癌症的组合疗法
|